AgaçMTKorkmazLCavusogluG. Association between nonalcoholic fatty liver disease and coronary artery disease complexity in patients with acute coronary syndrome: a pilot study [published online February 25, 2013]. Angiology. 2013. doi:10.1177/0003319713479155
2.
MasoudkabirFKarbalaiSVasheghani-FarahaniA. The association of liver transaminase activity with presence and severity of premature coronary artery disease. Angiology. 2011;62(8):614–619.
3.
ErogluSSadeLEPolatEBozbasHUlusTMuderrisogluH. Association between serum gamma-glutamyltransferase activity and carotid intima-media thickness. Angiology. 2011;62(2):107–110.
AthyrosVGElisafMSAlexandridesT. Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis. Angiology. 2012;63(5):358–366.
6.
LioudakiEVrentzosGEMavrogeniH. Prevalence of metabolic syndrome according to different definitions in a hypertensive population. Angiology. 2012;63(1):39–47.
7.
DemirkolSBaltaSUnluM. Neutrophils/lymphocytes ratio in patients with cardiac syndrome X and its association with carotid intima-media thickness [published online November 26, 2012]. Clin Appl Thromb Hemost. 2012.
8.
KostapanosMSElisafMSMikhailidisDP. Obstructive sleep apnea and cardiovascular risk: is metabolic syndrome the link?Angiology. 2012;63(8):569–573.
9.
AksakalETanbogaIHKurtM. Predictors of coronary lesions complexity in patients with stable coronary artery disease [published online November 20, 2012]. Angiology. 2012. doi:10.1177/0003319712464815
10.
FarooqVVergouweYRäberL. Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score. Eur Heart J. 2012;33(24):3098–3104.